M1 Kliniken AG

Informe acción XTRA:M12

Capitalización de mercado: €311.7m

M1 Kliniken Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Attila Strauss

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO2yrs
Participación del CEOn/a
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directiva2.1yrs

Actualizaciones recientes de la dirección

Recent updates

Does M1 Kliniken (ETR:M12) Have A Healthy Balance Sheet?

Oct 15
Does M1 Kliniken (ETR:M12) Have A Healthy Balance Sheet?

Earnings Not Telling The Story For M1 Kliniken AG (ETR:M12) After Shares Rise 27%

Sep 24
Earnings Not Telling The Story For M1 Kliniken AG (ETR:M12) After Shares Rise 27%

Why We're Not Concerned Yet About M1 Kliniken AG's (ETR:M12) 27% Share Price Plunge

Aug 03
Why We're Not Concerned Yet About M1 Kliniken AG's (ETR:M12) 27% Share Price Plunge

Additional Considerations Required While Assessing M1 Kliniken's (ETR:M12) Strong Earnings

Jun 06
Additional Considerations Required While Assessing M1 Kliniken's (ETR:M12) Strong Earnings

M1 Kliniken AG (ETR:M12) Looks Just Right With A 53% Price Jump

May 29
M1 Kliniken AG (ETR:M12) Looks Just Right With A 53% Price Jump

M1 Kliniken (ETR:M12) Might Be Having Difficulty Using Its Capital Effectively

May 03
M1 Kliniken (ETR:M12) Might Be Having Difficulty Using Its Capital Effectively

At €14.40, Is It Time To Put M1 Kliniken AG (ETR:M12) On Your Watch List?

Mar 07
At €14.40, Is It Time To Put M1 Kliniken AG (ETR:M12) On Your Watch List?

Why Investors Shouldn't Be Surprised By M1 Kliniken AG's (ETR:M12) 25% Share Price Surge

Feb 18
Why Investors Shouldn't Be Surprised By M1 Kliniken AG's (ETR:M12) 25% Share Price Surge

Is M1 Kliniken AG (ETR:M12) Trading At A 46% Discount?

Feb 17
Is M1 Kliniken AG (ETR:M12) Trading At A 46% Discount?

An Intrinsic Calculation For M1 Kliniken AG (ETR:M12) Suggests It's 27% Undervalued

Sep 01
An Intrinsic Calculation For M1 Kliniken AG (ETR:M12) Suggests It's 27% Undervalued

Should You Think About Buying M1 Kliniken AG (ETR:M12) Now?

Jun 01
Should You Think About Buying M1 Kliniken AG (ETR:M12) Now?

The Returns On Capital At M1 Kliniken (ETR:M12) Don't Inspire Confidence

Mar 25
The Returns On Capital At M1 Kliniken (ETR:M12) Don't Inspire Confidence

Investors Could Be Concerned With M1 Kliniken's (ETR:M12) Returns On Capital

Dec 17
Investors Could Be Concerned With M1 Kliniken's (ETR:M12) Returns On Capital

Is Now The Time To Look At Buying M1 Kliniken AG (ETR:M12)?

Nov 02
Is Now The Time To Look At Buying M1 Kliniken AG (ETR:M12)?

Time To Worry? Analysts Are Downgrading Their M1 Kliniken AG (ETR:M12) Outlook

May 26
Time To Worry? Analysts Are Downgrading Their M1 Kliniken AG (ETR:M12) Outlook

Analysts Have Lowered Expectations For M1 Kliniken AG (ETR:M12) After Its Latest Results

May 25
Analysts Have Lowered Expectations For M1 Kliniken AG (ETR:M12) After Its Latest Results

Here's What's Concerning About M1 Kliniken's (ETR:M12) Returns On Capital

Dec 06
Here's What's Concerning About M1 Kliniken's (ETR:M12) Returns On Capital

There Are Reasons To Feel Uneasy About M1 Kliniken's (ETR:M12) Returns On Capital

May 22
There Are Reasons To Feel Uneasy About M1 Kliniken's (ETR:M12) Returns On Capital

Here's What M1 Kliniken AG's (ETR:M12) Shareholder Ownership Structure Looks Like

Mar 19
Here's What M1 Kliniken AG's (ETR:M12) Shareholder Ownership Structure Looks Like

We're Watching These Trends At M1 Kliniken (ETR:M12)

Feb 21
We're Watching These Trends At M1 Kliniken (ETR:M12)

M1 Kliniken (ETR:M12) Has Gifted Shareholders With A Fantastic 106% Total Return On Their Investment

Feb 03
M1 Kliniken (ETR:M12) Has Gifted Shareholders With A Fantastic 106% Total Return On Their Investment

Are Dividend Investors Getting More Than They Bargained For With M1 Kliniken AG's (ETR:M12) Dividend?

Jan 16
Are Dividend Investors Getting More Than They Bargained For With M1 Kliniken AG's (ETR:M12) Dividend?

M1 Kliniken AG's (ETR:M12) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Dec 29
M1 Kliniken AG's (ETR:M12) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Here's Why We Don't Think M1 Kliniken's (ETR:M12) Statutory Earnings Reflect Its Underlying Earnings Potential

Dec 14
Here's Why We Don't Think M1 Kliniken's (ETR:M12) Statutory Earnings Reflect Its Underlying Earnings Potential

When Should You Buy M1 Kliniken AG (ETR:M12)?

Nov 28
When Should You Buy M1 Kliniken AG (ETR:M12)?

CEO

Attila Strauss

2yrs

Permanencia

Mr. Attila Strauss is Member of Management Board & Chief Executive Officer of M1 Kliniken AG since November 24, 2022 and March 2023 respectively. He studied International Trade Management (B.A.) and Inform...


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Sabine Meck
Member of Supervisory Board9.4yrssin datossin datos
Uwe Zimdars
Chairman of Supervisory Board2.1yrssin datossin datos
Dirk Hempel
Deputy Chairman of Supervisory Board2.1yrssin datossin datos

2.1yrs

Permanencia media

Junta con experiencia: La junta directiva de M12 no se considera experimentada (2.1 años de permanencia promedio), lo que sugiere una nueva junta directiva.